Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors

Neurosurgery
J E ThomasS L Giannotta

Abstract

To determine the capability of donors of nitric oxide (NO) (sodium nitroprusside, nitroglycerine) to reverse endothelin-1 (ET-1)-induced cerebral vasoconstriction in vivo, when administered through the cerebrospinal fluid (CSF) to the adventitial side of the constricted blood vessel. The rabbit basilar artery was exposed through a transcervical, transclival approach and subsequently subjected to pharmacological manipulations and direct observation of effects by videomicroscopy. Specific manipulations were suffusion of ET-1 (100 nmol/L, 1 ml/min) in synthetic CSF (sCSF) to provoke vasoconstriction and then either suffusion of an NO donor in sCSF (2 mg/ml/min), or sCSF alone. The second suffusion was always made separately and begun during the period of stable maximal vasoconstriction, which occurred between 20 and 30 minutes after beginning the first suffusion. Measurements of the diameter of the artery were made using an inline video caliper. Sodium nitroprusside and nitroglycerine, both donors of NO, rapidly and completely reversed ET-1-induced vasoconstriction without causing hypotension. The average value for maximal vasoconstriction by ET-1/sCSF was 50.4% of baseline arterial diameter and occurred between 20 and 30 minutes....Continue Reading

References

Dec 28, 1992·Science·E Culotta, D E Koshland
May 1, 1992·Scientific American·S H Snyder, D S Bredt
Aug 1, 1992·Journal of Neurosurgery·E H Ohlstein, B L Storer
Nov 1, 1993·Neurologia Medico-chirurgica·I FuwaZ Luo
Oct 1, 1993·Neurological Research·N EgemenJ M McCormick
Sep 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Y HenryA Guissani
May 23, 1957·The Journal of Physiology·W H GIBSON, F J ROUGHTON
Feb 1, 1963·Journal of Neurosurgery·R B RAYNOR, J G MCMURTRY

❮ Previous
Next ❯

Citations

Nov 4, 2000·Expert Opinion on Investigational Drugs·K K Jain
Nov 20, 1998·Journal of Cardiovascular Pharmacology·M KimuraJ T Robertson
Oct 28, 2008·Neurological Research·Marc L OttenRobert A Solomon
Feb 23, 2013·Neurology Research International·Ioannis SiasiosKostas N Fountas
Mar 18, 2008·Drug Discovery Today·R Webster CrowleyAaron S Dumont

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.